Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
Despite it's popularity, some individuals experience an allergic reaction to cinnamon. Learn more about the symptoms and treatments for this allergy.
Researchers have identified a new brain signaling pathway that alleviates depression when blocked; the discovery could open the door to new treatments.
People with a gene defect have greater preferences for high-fat, but not high sugar foods, drawing a direct link between food choice and genetic variants.